Clinical Trial: Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma

U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06837922) titled 'Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma' on Feb. 04.

Brief Summary: To assess the safety and tolerability of a single subcutaneous administration of MG-K10 in healthy subjects, with secondary objectives to evaluate pharmacokinetic (PK) profile, pharmacodynamic (PD) effects, and possible immunogenicity.

Study Start Date: Feb. 02

Study Type: INTERVENTIONAL

Condition: Asthma

Intervention: DRUG: MG-K10/Placebo

MG-K10 Humanized Monoclonal Antibody Injection

Recruitment Status: RECRUITING

Sponsor: Shanghai Mabgeek Biotech.Co.Ltd

Disclaimer: Curated by HT Syndication....